| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2011-07-06 11:32:41 UTC |
|---|
| Update Date | 2022-03-07 02:51:34 UTC |
|---|
| HMDB ID | HMDB0013648 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Palmitoleoylethanolamde |
|---|
| Description | Palmitoleoylethanolamde (POEA), belongs to the class of organic compounds known as N-acylethanolamines. N-Acylethanolamines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of ethanolamine. Thus, palmitoleoylethanolamde is considered to be a fatty amide lipid molecule. Palmitoleoylethanolamde is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. During abstinence, young adults with a history of alcohol binge drinking had elevated plasma levels of monounsaturated and polyunsaturatedacylethanolamides, specifically oleoylethanolamide (OEA), palmitoleoylethanolamide (POEA), arachidonoylethanolamide (AEA), and dihomo-gamma-linolenoylethanolamide (DGLEA). Changes in these lipids positively correlated with mRNA upregulation of inflammatory markers in peripheral blood mononuclear cells (PBMCs), such as toll-like receptors (TLR4), pro-inflammatory cytokines/chemokines, and cyclooxygenase-2 (PMID: 29178411 ). |
|---|
| Structure | CCCCCC\C=C/CCCCCCCC(=O)NCCO InChI=1S/C18H35NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)19-16-17-20/h7-8,20H,2-6,9-17H2,1H3,(H,19,21)/b8-7- |
|---|
| Synonyms | | Value | Source |
|---|
| (Z)-Hexadec-9-enoyl ethanolamide | ChEBI | | N-(2-Hydroxyethyl)palmitoleylamide | ChEBI | | N-(9Z-Hexadecenoyl) ethanolamine | ChEBI | | N-(9Z-Hexadecenoyl)-ethanolamine | ChEBI | | Palmitoleoyl-ea | ChEBI | | POEA | ChEBI | | Polyoxyethyleneamine | MeSH | | N-(9Z-Hexadecenoyl)-ethanolamide | HMDB | | Palmitoleoyl-ethanolamide | HMDB | | Palmitoleoyl-ethanolamine | HMDB | | (9Z)-N-(2-Hydroxyethyl)-9-hexadecenamide | HMDB | | Palmitoleoyl ethanolamide | HMDB |
|
|---|
| Chemical Formula | C18H35NO2 |
|---|
| Average Molecular Weight | 297.476 |
|---|
| Monoisotopic Molecular Weight | 297.266779369 |
|---|
| IUPAC Name | (9Z)-N-(2-hydroxyethyl)hexadec-9-enamide |
|---|
| Traditional Name | palmitoleoyl-EA |
|---|
| CAS Registry Number | 94421-67-7 |
|---|
| SMILES | CCCCCC\C=C/CCCCCCCC(=O)NCCO |
|---|
| InChI Identifier | InChI=1S/C18H35NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)19-16-17-20/h7-8,20H,2-6,9-17H2,1H3,(H,19,21)/b8-7- |
|---|
| InChI Key | WFRLANWAASSSFV-FPLPWBNLSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as n-acylethanolamines. N-acylethanolamines are compounds containing an N-acyethanolamine moiety, which is characterized by an acyl group is linked to the nitrogen atom of ethanolamine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic nitrogen compounds |
|---|
| Class | Organonitrogen compounds |
|---|
| Sub Class | Amines |
|---|
| Direct Parent | N-acylethanolamines |
|---|
| Alternative Parents | |
|---|
| Substituents | - N-acylethanolamine
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Alcohol
- Organooxygen compound
- Primary alcohol
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 9.47 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 18.3875 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.17 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2770.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 366.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 205.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 208.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 557.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 795.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 627.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 164.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1731.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 579.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1677.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 589.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 451.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 390.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 372.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Palmitoleoylethanolamde,1TMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)NCCO[Si](C)(C)C | 2518.0 | Semi standard non polar | 33892256 | | Palmitoleoylethanolamde,1TMS,isomer #2 | CCCCCC/C=C\CCCCCCCC(=O)N(CCO)[Si](C)(C)C | 2477.9 | Semi standard non polar | 33892256 | | Palmitoleoylethanolamde,2TMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)N(CCO[Si](C)(C)C)[Si](C)(C)C | 2520.2 | Semi standard non polar | 33892256 | | Palmitoleoylethanolamde,2TMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)N(CCO[Si](C)(C)C)[Si](C)(C)C | 2558.9 | Standard non polar | 33892256 | | Palmitoleoylethanolamde,2TMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)N(CCO[Si](C)(C)C)[Si](C)(C)C | 2515.8 | Standard polar | 33892256 | | Palmitoleoylethanolamde,1TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)NCCO[Si](C)(C)C(C)(C)C | 2735.1 | Semi standard non polar | 33892256 | | Palmitoleoylethanolamde,1TBDMS,isomer #2 | CCCCCC/C=C\CCCCCCCC(=O)N(CCO)[Si](C)(C)C(C)(C)C | 2692.9 | Semi standard non polar | 33892256 | | Palmitoleoylethanolamde,2TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)N(CCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2978.4 | Semi standard non polar | 33892256 | | Palmitoleoylethanolamde,2TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)N(CCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2895.9 | Standard non polar | 33892256 | | Palmitoleoylethanolamde,2TBDMS,isomer #1 | CCCCCC/C=C\CCCCCCCC(=O)N(CCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2713.2 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Palmitoleoylethanolamde GC-MS (Non-derivatized) - 70eV, Positive | splash10-006t-9850000000-dca871694e1453ee1290 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Palmitoleoylethanolamde GC-MS (1 TMS) - 70eV, Positive | splash10-00dj-9432000000-461ac4f924d74371dcfa | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Palmitoleoylethanolamde GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Palmitoleoylethanolamde GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Palmitoleoylethanolamde 10V, Positive-QTOF | splash10-0002-0090000000-431ef9175cd6e2c98ac5 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Palmitoleoylethanolamde 20V, Positive-QTOF | splash10-001j-3090000000-fd112625084534fd104f | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Palmitoleoylethanolamde 40V, Positive-QTOF | splash10-001i-9000000000-c67f4ac6eb06f01e12ff | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Palmitoleoylethanolamde 10V, Positive-QTOF | splash10-01ot-3090000000-d6769586b97d92aec922 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Palmitoleoylethanolamde 20V, Positive-QTOF | splash10-03dl-9130000000-e2b3de7dda39a1a2b8e7 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Palmitoleoylethanolamde 40V, Positive-QTOF | splash10-01ox-9310000000-3a6ec9ee35e9c5b6fcb5 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Palmitoleoylethanolamde 10V, Negative-QTOF | splash10-0002-0090000000-2bc9024817a3bec1dab5 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Palmitoleoylethanolamde 20V, Negative-QTOF | splash10-01r2-4090000000-29e8051940c6da6e4f7f | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Palmitoleoylethanolamde 40V, Negative-QTOF | splash10-0006-9010000000-5d6e43f9124267c45344 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Palmitoleoylethanolamde 10V, Positive-QTOF | splash10-01ot-9080000000-d5b6efef796a3944fdee | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Palmitoleoylethanolamde 20V, Positive-QTOF | splash10-03dl-9000000000-580ee14b795a28da936b | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Palmitoleoylethanolamde 40V, Positive-QTOF | splash10-01ox-9000000000-0796fb6e81f9d4eed35f | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Palmitoleoylethanolamde 10V, Negative-QTOF | splash10-0002-0090000000-69f5cee9787e872ffdd7 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Palmitoleoylethanolamde 20V, Negative-QTOF | splash10-0002-3190000000-42b64e70a801d7da5829 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Palmitoleoylethanolamde 40V, Negative-QTOF | splash10-059f-9110000000-ab8fbfe293d1e35072db | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Syed SK, Bui HH, Beavers LS, Farb TB, Ficorilli J, Chesterfield AK, Kuo MS, Bokvist K, Barrett DG, Efanov AM: Regulation of GPR119 receptor activity with endocannabinoid-like lipids. Am J Physiol Endocrinol Metab. 2012 Dec 15;303(12):E1469-78. doi: 10.1152/ajpendo.00269.2012. Epub 2012 Oct 16. [PubMed:23074242 ]
- Anton M, Rodriguez-Gonzalez A, Rodriguez-Rojo IC, Pastor A, Correas A, Serrano A, Ballesta A, Alen F, Gomez de Heras R, de la Torre R, Rodriguez de Fonseca F, Orio L: Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women. Addict Biol. 2018 Nov;23(6):1242-1250. doi: 10.1111/adb.12580. Epub 2017 Nov 27. [PubMed:29178411 ]
|
|---|